2025 HCPCS code J3246
Injection, tirofiban HCL, 0.25 mg
Medical necessity is determined by the diagnosis and the clinical indication for the administration of tirofiban hydrochloride.
Administering tirofiban hydrochloride intravenously as per prescribed dosage and monitoring patient response.
In simple words: This injection helps prevent blood clots, often used during procedures like angioplasty or for heart attack treatment. The medicine is called tirofiban, and the code is for a specific amount given.
Tirofiban hydrochloride is an anticoagulant drug administered intravenously to prevent blood clots. It's used in conjunction with other medications for conditions like heart attacks and angioplasty procedures. This code is billed per 0.25 mg dosage.
Example 1: A patient undergoing angioplasty receives tirofiban hydrochloride to prevent clot formation during and after the procedure., A patient experiencing a heart attack is given tirofiban hydrochloride to minimize blood clotting and further cardiac damage., A patient with unstable angina is administered tirofiban to reduce the risk of acute coronary events.
Dosage administered, route of administration (IV), patient response, any adverse reactions.
- Payment Status: Active
- Specialties:Cardiology, Interventional Radiology
- Place of Service:Inpatient Hospital, On Campus-Outpatient Hospital, Ambulatory Surgical Center, and other places of service where intravenous medications can be administered.